# Progress Note 06 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Cleopatra (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-AC003-SYN
- Date: 2026-08-18
- Fictional facility: St. Posthumous Health Center
- Fictional author: Nefeli Arvanitis-Osei, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Prenatal visit at 33 weeks: growth scan, Tdap, and the delivery plan. **S**

## History of present illness

Cleopatra returns at 33 weeks 0 days. The visit and growth scan planned for 29 weeks did not take place: the scan request was not sent when the visit was booked, the visit was cancelled when no scan slot appeared, and neither was rebooked until she called the clinic last week. She has felt well. She has had no headache, visual change, upper abdominal pain, swelling of the face or hands, breathlessness, bleeding, leaking fluid, or regular tightenings; she has occasional painless tightenings in the evening. Both babies move often. She takes aspirin, the prenatal vitamin, and ferrous sulfate every other day. She has stopped evening meetings and plans to stop work at 36 weeks. She had the growth scan this morning and wants to plan the birth. **S**

| Element | Detail |
|---|---|
| Missed care | The 29-week visit and growth scan did not take place |
| Symptoms | None of preeclampsia; occasional painless evening tightenings |
| Fetal movement | Both babies moving often |
| Plans | Stopping work at 36 weeks |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Well; tired by evening |
| Cardiovascular | Negative | No breathlessness or palpitations |
| Neurological | Negative | No headache or visual change |
| Gastrointestinal | Negative | No upper abdominal pain; mild heartburn |
| Genitourinary | Negative | No bleeding, leaking fluid, or urinary symptoms |
| Psychiatric | Negative | Calm and looking forward; EPDS 6 |

6 systems reviewed. **S**

## Current medications

- Prenatal vitamin containing folic acid 0.4 mg, one tablet by mouth daily **S**
- Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day **S**
- Aspirin 81 mg delayed-release tablet, one tablet by mouth at bedtime **S**

## Allergies

- No known allergy **S**

## Objective

BP 114/72 mmHg; pulse 92 bpm; respirations 16/min; temperature 36.8 °C; oxygen saturation 99% on room air; weight 70.5 kg; BMI 25.9 kg/m². All vital signs are synthetic.

Hemoglobin: 11 g/dL; Platelets: 226 10*3/uL; Estimated fetal weight, twin A: 2050 g; Estimated fetal weight, twin B: 1890 g; EPDS: 6. All results are synthetic.

## Change since baseline

- Hemoglobin: 10.8 g/dL (low) at baseline, 11 g/dL at this visit **S**
- Platelets: 268 10*3/uL at baseline, 226 10*3/uL at this visit **S**
- EPDS: 6 at baseline, 6 at this visit **S**

## Immunizations given today

- Tdap vaccine in pregnancy, 33 weeks **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well |
| Abdomen | Fundal height 38 cm, consistent with twins at 33 weeks; non-tender |
| Fetal | Scan: twin A cephalic, 2050 g; twin B breech, 1890 g; discordance 8 percent; normal fluid; fetal hearts 140 and 136 per minute |
| Extremities | Trace ankle edema; no calf tenderness |
| Urine dipstick | Protein negative |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Twin pregnancy, dichorionic diamniotic** (O30.041). Blood pressure 114/72 mmHg, urine protein negative, and no symptoms of preeclampsia after the missed visit. Concordant growth (8 percent) with normal fluid and Doppler; twin A cephalic, twin B breech. Hemoglobin 11.0 g/dL; platelets 226. EPDS 6 with item 10 scored 0. Weight gain 12.5 kg so far, on track. **S**
   - Tdap given today.
   - Visits every two weeks until 36 weeks, then weekly, with blood pressure and urine protein each time; growth scan at 36 to 37 weeks.
   - Group B streptococcus swab at 36 to 37 weeks; RSV vaccine at 36 weeks, once the season begins in September.
   - Weekly fetal heart rate testing from 36 weeks, which can be offered for twins.
   - Continue aspirin until delivery.
2. **Delivery plan**. For uncomplicated dichorionic twins, birth is recommended at 38 0/7 to 38 6/7 weeks. With twin A head down, vaginal birth is reasonable whatever twin B's position, with a clinician experienced in breech extraction or internal version; cesarean if twin A is not head down. Twins raise the risk of postpartum hemorrhage. **S**
   - She chose induction at 38 weeks 0 days at the hospital, which has a neonatal intensive care unit.
   - Epidural advised early in labor; birth in the operating room with the team ready for a cesarean for twin B if needed.
   - Active management of the third stage with oxytocin and quantitative blood loss.
   - Antenatal corticosteroids only if birth before 34 weeks is threatened.
   - She will arrange for her household to take her to the hospital at any hour.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure and urine protein | Every prenatal visit | Completed today | 114/72 mmHg; urine protein negative |
| Examination | Prenatal visit and growth scan at 29 weeks | Every four weeks for growth scans; visits every two weeks from 28 weeks | Deferred | Missed: the 29-week visit and growth scan did not take place because the scan request was not sent and the cancelled visit was not rebooked. No harm found today: blood pressure 114/72 mmHg, no proteinuria, no symptoms, and concordant growth with normal fluid on today's scan. Corrective action: all remaining visits and the 36-week scan were booked together today, and the clinic is reviewing how scan requests are linked to visits |
| Examination | Fetal hearts and fundal height | Every prenatal visit | Completed today | Fetal hearts 140 and 136 per minute; fundal height 38 cm |
| Examination | Weight gain (about 17 to 25 kg for twins from a normal BMI) | Every prenatal visit | Completed today | 70.5 kg, up 12.5 kg since intake |
| Imaging | Growth scan with discordance | Every four weeks from about 20 to 24 weeks in a dichorionic twin pregnancy | Completed today | 2050 and 1890 g; discordance 8 percent; normal fluid and Doppler; twin A cephalic, twin B breech |
| Laboratory | Hemoglobin and ferritin | At intake, at the anatomy-scan visit, at 24 to 28 weeks, and in the third trimester | Completed today | Hemoglobin 11.0 g/dL; platelets 226 |
| Survey | Perinatal mood screen (EPDS) | Each trimester | Completed today | 6; item 10 scored 0 |
| Medication safety | Tdap vaccine | Once at 27 to 36 weeks in every pregnancy | Completed today | Given today |
| Medication safety | RSV vaccine | At 32 to 36 weeks from September to January | Due | At the 36-week visit in September |
| Laboratory | Group B streptococcus culture | At 36 0/7 to 37 6/7 weeks | Due | At the 36-week visit |
| Examination | Weekly antenatal fetal testing | May be considered from 36 0/7 weeks in uncomplicated dichorionic twins | Due | From 36 weeks |
| Medication safety | Low-dose aspirin | Daily from 12 weeks until delivery; review at every visit | Completed today | Taken nightly; continue until delivery |
| Self-management | Delivery timing and place | Agreed by 34 weeks | Completed today | Induction at 38 weeks 0 days at the hospital with a neonatal intensive care unit |
| Self-management | Preterm labor warning signs | Every prenatal visit | Completed today | Occasional painless evening tightenings only; warning signs reviewed |

## Goal progress

- The cause of the large uterus and the dating of the pregnancy established at the 11-week scan. Outcome by 2026-03-17: Dichorionic diamniotic twins; dating by her last period confirmed by the crown-rump lengths. **S**
- An informed choice about aneuploidy screening by 14 weeks. Outcome by 2026-03-17: Chose nuchal translucency for each twin with cell-free DNA; declined diagnostic testing for now. **S**
- Hemoglobin and ferritin in the normal range for pregnancy by the third trimester. Outcome by 2026-08-18: Ferritin 31 ng/mL at 25 weeks; hemoglobin 11.0 g/dL at 33 weeks. **S**
- Growth discordance under 20 percent at every growth scan. Outcome by 2026-08-18: Discordance 5 percent at 25 weeks and 8 percent at 33 weeks. **S**
- A written delivery plan agreed by 34 weeks. Outcome by 2026-08-18: Planned birth at 38 weeks 0 days in the hospital, with a vaginal birth while twin A is head down, an epidural, and the operating room ready. **S**

## Guideline basis

- Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies: ACOG Practice Bulletin, Number 231 (2021), American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine (Obstetrics & Gynecology)
- Medically Indicated Late-Preterm and Early-Term Deliveries: ACOG Committee Opinion, Number 831 (2021), American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine (Obstetrics & Gynecology)
- Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234 (2021), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021), U.S. Preventive Services Task Force
- Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum: ACOG Clinical Practice Guideline No. 4 (2023), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Guidelines for Vaccinating Pregnant Persons (2026), Centers for Disease Control and Prevention

## Follow-up

- Prenatal visits every two weeks until 36 weeks, then weekly; growth scan at 36 to 37 weeks; induction at 38 weeks 0 days. **S**

